sargramostim
Showing 1 - 25 of 536
Solid Tumor, Solid Tumor, Adult Trial (Sargramostim, Ipilimumab-containing therapy)
Suspended
- Solid Tumor
- Solid Tumor, Adult
- Sargramostim
- Ipilimumab-containing therapy
-
Lexington, MassachusettsPartner Therapeutics - No Currently Active Sites
Nov 30, 2022
Parkinson's Disease and Parkinsonism Trial in Omaha (Sargramostim)
Not yet recruiting
- Parkinson's Disease and Parkinsonism
- Sargramostim
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Dec 22, 2022
Drug Kinetics, Drug Effects on Physiology Trial in Mount-Royal (sargramostim)
Completed
- Drug Kinetics
- Drug Effects on Physiology
- sargramostim
-
Mount-Royal, Quebec, CanadaAltaSciences
Sep 30, 2022
Unresectable Melanoma, Metastatic Melanoma, Stage III Melanoma Trial in Boston (Sargramostim (GM-CSF), Pembrolizumab
Recruiting
- Unresectable Melanoma
- +3 more
- Sargramostim (GM-CSF)
- Pembrolizumab (anti-PD-1)
-
Boston, Massachusetts
- +1 more
Jul 6, 2022
Down Syndrome Trial in Aurora (Sargramostim for Injection, Saline Placebo)
Not yet recruiting
- Down Syndrome
- Sargramostim for Injection
- Saline Placebo
-
Aurora, ColoradoUniversity of Colorado Anschutz Medical Campus
Jul 28, 2022
Alzheimer Trial in Aurora (Sargramostim, Saline - comparator)
Recruiting
- Alzheimer Disease
- Sargramostim
- Saline - placebo comparator
-
Aurora, ColoradoUniversity of Colorado Anschutz Medical Campus
Jul 19, 2022
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Lung, Metastatic Melanoma Trial in Rochester
Not yet recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +4 more
- Aerosol Sargramostim
- +5 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 30, 2023
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Baltimore (Azacitidine, Sargramostim)
Completed
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Azacitidine
- Sargramostim
-
Baltimore, MarylandThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sep 23, 2022
Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Buffalo (sargramostim)
Completed
- Chronic Myeloproliferative Disorders
- +5 more
- sargramostim
-
Buffalo, New YorkRoswell Park Cancer Institute
Oct 3, 2022
Parkinson Disease Trial in Omaha (sargramostim)
Active, not recruiting
- Parkinson Disease
- sargramostim
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Oct 19, 2022
Transplant-Related Hematologic Malignancy Trial in Atlanta (Sargramostim, Control Arm)
Recruiting
- Transplant-Related Hematologic Malignancy
- Sargramostim
- Control Arm
-
Atlanta, GeorgiaNorthside Hospital
Oct 19, 2022
Childhood Astrocytoma, Childhood Atypical Teratoid/Rhabdoid Tumor, Diffuse Intrinsic Pontine Glioma Trial in Rochester
Active, not recruiting
- Childhood Astrocytoma
- +9 more
- Laboratory Biomarker Analysis
- +2 more
-
Rochester, MinnesotaMayo Clinic
Sep 8, 2022
HER2-positive Breast Cancer, Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor Trial in Seattle
Active, not recruiting
- HER2-positive Breast Cancer
- +8 more
- pNGVL3-hICD vaccine
- +6 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Nov 1, 2022
Transitional Cell Carcinoma Trial in New York (TICEĀ®-strain BCG, NY-ESO-1 protein, sargramostim)
Completed
- Transitional Cell Carcinoma
- TICEĀ®-strain BCG
- +2 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Oct 3, 2022
COVID-19, SARS-CoV-2 Trial in United States (Sargramostim, Standard of care)
Completed
- COVID-19
- SARS-CoV-2
- Sargramostim
- Standard of care
-
Fullerton, California
- +10 more
Feb 16, 2022
COVID-19 Trial in Japan (Sargramostim, Placebo)
Completed
- COVID-19
- Sargramostim
- Placebo
-
Narita City, Chiba, Japan
- +6 more
Nov 1, 2021
Neuroblastoma Recurrent Trial in Hong Kong (Natural killer cell, Dinutuximab beta, Interleukin-2)
Recruiting
- Neuroblastoma Recurrent
- Natural killer cell
- +4 more
-
Hong Kong, Hong KongHong Kong Children's Hospital
Feb 22, 2023
Diffuse, Large B-Cell, Lymphoma Trial in Los Angeles (Rituximab)
Completed
- Diffuse, Large B-Cell, Lymphoma
-
Los Angeles, CaliforniaUSC Norris Comprehensive Cancer Center
Nov 15, 2021
Autoimmune Pulmonary Alveolar Proteinosis Trial in Los Altos, Cincinnati (Sargramostim)
Completed
- Autoimmune Pulmonary Alveolar Proteinosis
- Sargramostim
-
Los Altos, California
- +1 more
Aug 2, 2021
Mantle Cell Lymphoma, Lymphoma, Mantle Cell Trial run by the NCI (EPOCH-R, GM-CSF, Idiotype vaccine)
Completed
- Mantle Cell Lymphoma
- Lymphoma, Mantle Cell
- EPOCH-R
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 4, 2023
Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in Aurora (cryotherapy, sargramostim)
Completed
- Recurrent Prostate Cancer
- +3 more
- cryotherapy
- sargramostim
-
Aurora, ColoradoUniversity of Colorado Cancer Center
Feb 8, 2022
Neuroblastoma Trial in Cologne (antibody ch14.18, GM-CSF, IL-2 i.v.)
Terminated
- Neuroblastoma
- antibody ch14.18
- +4 more
-
Cologne, GermanyUniversity of Cologne
Nov 3, 2022
Relapsed Neuroblastoma, Refractory Neuroblastoma Trial (Natural Killer Cells, Temozolomide, Irinotecan)
Recruiting
- Relapsed Neuroblastoma
- Refractory Neuroblastoma
- Natural Killer Cells
- +4 more
-
Columbus, OhioNationwide Children's Hospital
Oct 26, 2022
Advanced Ovarian Cancer Trial in Seattle (AST-201, Paclitaxel, Carboplatin)
Not yet recruiting
- Advanced Ovarian Cancer
- AST-201
- +4 more
-
Seattle, WashingtonUniversity of Washington
Mar 20, 2023
Partial Response of Multiple Myeloma or Plasma Cell Leukemia, Plasma Cell Myeloma Trial in Buffalo, Rochester (biological,
Active, not recruiting
- Partial Response of Multiple Myeloma or Plasma Cell Leukemia
- Plasma Cell Myeloma
- Incomplete Freund's Adjuvant
- +4 more
-
Buffalo, New York
- +1 more
Dec 12, 2022